Crateva adansonii
Crateva adansonii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Crateva adansonii is a botanical species recognized for its significant pharmacological potential in treating various health conditions. Scientific investigations have focused on its leaves, particularly through the use of methanol and chloroform leaf extracts (ME and CE). These studies aim to evaluate the plant's medicinal activities, specifically its ability to act as an analgesic and combat inflammation. The therapeutic efficacy is attributed to key chemical constituents such as daucosterol, kaempferol, quercetin, and the lupeol fraction (LF). By analyzing these specific extracts, researchers continue to uncover the medicinal value of this plant's chemical profile.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Capparaceae
- Distribution
- Northern America
- Plant Parts
- Leaf
Classification
Common Names
Crateva adansonii is a versatile plant recognized by a diverse array of regional and international names. It is widely known as Eiyoroit or Koleonik in certain locales, showcasing its deep roots in local cultures. In other areas, the species is frequently referred to as Nagarida, reflecting its widespread geographic distribution. Many enthusiasts and botanists also recognize it by its descriptive English name, the Sacred Garlic Pear. Finally, its global presence is further highlighted by its designation in other languages, such as Кратева Адансона.
Sources: Catalogue of Life (COL)
Taxonomy
Crateva adansonii is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast realm, the species is classified under the class Equisetopsida. It is further organized into the order Brassicales, showcasing its evolutionary connections to other unique plants. As a member of the family Capparaceae, it shares specific biological traits with its relatives. Finally, this plant is distinctively identified by its placement within the genus Crateva.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Brassicales |
| Family | Capparaceae |
| Genus | Crateva |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Crateva adansonii is a distinctive plant species with a wide distribution across several regions of the African continent. It is commonly found throughout East Tropical Africa, specifically within the territories of Kenya, Tanzania, and Uganda. Moving toward the north, the plant also thrives in the Northeast Tropical Africa region. Within this area, it has established a presence in countries such as Chad and Eritrea. This diverse range highlights the plant's ability to adapt to various ecological landscapes across East and Northeast Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Crateva adansonii grows in the form of a sturdy, self-supporting tree. This species typically reaches a maximum height of 6 meters as it matures. Its structural integrity allows it to stand firmly within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Crateva adansonii is an Indian traditional medicinal plant that has demonstrated significant pharmacological potential in recent studies. Researchers have focused on isolating lupeol, a bioactive triterpenoid from its leaves, to explore its therapeutic properties. Through in vivo assays such as the hot plate and acetic acid-induced writhing tests, the plant has shown notable analgesic activity. Furthermore, the lupeol fraction exhibited strong effects in managing pain and inflammation, even outperforming standard reference drugs in certain biological parameters. These findings suggest that Crateva adansonii could serve as a valuable, natural source for developing effective multi-target pain relief treatments.
Compounds
Crateva adansonii is a versatile medicinal plant recognized for its diverse range of bioactive chemical constituents. Research identifies daucosterol within the plant as a major anticancer principle capable of inhibiting prostate carcinoma cell growth. Additionally, the presence of lupeol provides significant analgesic and anti-inflammatory potential, offering a promising natural alternative to traditional synthetic drugs. The plant also contains important flavonoids, specifically quercetin and kaempferol, which contribute to its therapeutic efficacy. Together, these compounds support the plant's traditional uses in treating inflammation, tumors, and other various health conditions.
Conditions
Crateva adansonii serves as an effective treatment for inflammation by utilizing its bioactive compounds to target key inflammatory markers. Research demonstrates that the plant treats acute inflammation, specifically through its ability to mitigate carrageenan-induced rat paw edema. Furthermore, the plant is capable of treating chronic inflammation, showing significant inhibition in various experimental models. It also effectively treats cotton pellet-induced granuloma, proving its versatility in managing different inflammatory responses. Collectively, these findings highlight the medicinal potential of Crateva adansonii in treating diverse inflammatory conditions.
Preparations
Crateva adansonii is prepared as an extract to study its various pharmacological properties. Specifically, the plant is prepared as a leaf extract to isolate bioactive compounds like lupeol. Researchers also utilize methanol and chloroform leaf extracts (ME and CE) of Crateva adansonii for in vivo investigations. Furthermore, the plant is prepared as a lupeol fraction (LF) to evaluate its significant analgesic and anti-inflammatory potential. These different preparations of Crateva adansonii allow for the detailed screening of its medicinal efficacy.
Parts used
Crateva adansonii is a traditional Indian medicinal plant belonging to the Capparaceae family that offers significant therapeutic benefits. Researchers have focused specifically on the plant's leaf, utilizing methanol and chloroform extracts to study its medicinal properties. From these leaf extracts, the bioactive compound lupeol was successfully isolated to test its pharmacological potential. In vivo studies demonstrate that this leaf-derived lupeol fraction possesses potent analgesic and anti-inflammatory activities. Ultimately, these findings highlight the importance of the Crateva adansonii leaf as a valuable source for developing new pharmaceutical treatments.